Literature DB >> 26978213

Suppression of Substance Abuse Claims in Medicaid Data and Rates of Diagnoses for Non-Substance Abuse Conditions.

Kathryn Rough1, Brian T Bateman1, Elisabetta Patorno1, Rishi J Desai1, Yoonyoung Park1, Sonia Hernandez-Diaz2, Krista F Huybrechts1.   

Abstract

Entities:  

Mesh：

Year:  2016        PMID： 26978213      PMCID： PMC4794113          DOI： 10.1001/jama.2015.18417

Source DB:  PubMed          Journal:  JAMA        ISSN： 0098-7484            Impact factor:   56.272


× No keyword cloud information.
  1 in total

1.  Protection or harm? Suppressing substance-use data.

Authors:  Austin B Frakt; Nicholas Bagley
Journal:  N Engl J Med       Date:  2015-04-15       Impact factor: 91.245
  1 in total
  9 in total

1.  Interpretation and integration of the federal substance use privacy protection rule in integrated health systems: A qualitative analysis.

Authors:  Aimee N C Campbell; Dennis McCarty; Traci Rieckmann; Jennifer McNeely; John Rotrosen; Li-Tzy Wu; Gavin Bart
Journal:  J Subst Abuse Treat       Date:  2018-11-19

2.  Ten-year trends in antiretroviral therapy persistence among US Medicaid beneficiaries.

Authors:  Bora Youn; Theresa I Shireman; Yoojin Lee; Omar Galárraga; Aadia I Rana; Amy C Justice; Ira B Wilson
Journal:  AIDS       Date:  2017-07-31       Impact factor: 4.177

3.  Redaction of Substance Abuse Claims in Medicare Research Files Affects Spending Outcomes for Nearly One in Five Beneficiaries with Serious Mental Illness.

Authors:  Pamela Roberto; Nicole Brandt; Eberechukwu Onukwugha; Bruce Stuart
Journal:  Health Serv Res       Date:  2016-07-24       Impact factor: 3.402

4.  Costs of substance use disorders from claims data for Medicare recipients from a population-based sample.

Authors:  Brian J Fairman; Seungyoung Hwang; Pierre K Alexandre; Joseph J Gallo; William W Eaton
Journal:  J Subst Abuse Treat       Date:  2017-02-24

5.  Using prescription claims to detect aberrant behaviors with opioids: comparison and validation of 5 algorithms.

Authors:  Kathryn Rough; Krista F Huybrechts; Sonia Hernandez-Diaz; Rishi J Desai; Elisabetta Patorno; Brian T Bateman
Journal:  Pharmacoepidemiol Drug Saf       Date:  2018-04-24       Impact factor: 2.890

6.  Long-Term Implications Of A Short-Term Policy: Redacting Substance Abuse Data.

Authors:  Andrea M Austin; Julie P W Bynum; Donovan T Maust; Daniel J Gottlieb; Ellen Meara
Journal:  Health Aff (Millwood)       Date:  2018-06       Impact factor: 6.301

7.  Relationship between buprenorphine adherence and relapse, health care utilization and costs in privately and publicly insured patients with opioid use disorder.

Authors:  Naoko A Ronquest; Tina M Willson; Leslie B Montejano; Vijay R Nadipelli; Bernd A Wollschlaeger
Journal:  Subst Abuse Rehabil       Date:  2018-09-21

Review 8.  Recommendations to Inform Substance Use Disorder Data Sharing Research: Scoping Review and Thematic Analysis.

Authors:  George Karway; Julia Ivanova; Anweysha Bhowmik; Anita Murcko; Michael Saks; Dennis McCarty; Aimee Campbell; Maria Adela Grando
Journal:  J Addict Med       Date:  2022 May-Jun 01       Impact factor: 4.647

9.  Comparison of Utilization, Costs, and Quality of Medicaid vs Subsidized Private Health Insurance for Low-Income Adults.

Authors:  Heidi Allen; Sarah H Gordon; Dennis Lee; Aditi Bhanja; Benjamin D Sommers
Journal:  JAMA Netw Open       Date:  2021-01-04
  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.